Introduction
============

Borderline personality disorder (BPD) is a severe mental disorder characterized by deficits in emotion regulation, impulse control, interpersonal relationships and self-perception ([@B2]). Emotional dysregulation is a typical symptom of BPD. Patients are more sensitive to emotional stimuli ([@B41]) and frequently use maladaptive emotion regulation strategies, such as avoidance, impulsive behaviors, self blame and blaming others ([@B19]). Impulsivity is another core feature of BPD patients, who often show impulsive behavior, such as suicide attempts, binge eating, substance abuse, and unprotected sex ([@B31]). Furthermore, unstable and chaotic interpersonal relationship is common in BPD. Patients suffer from serious influences on psychosocial functioning issues ([@B36]). In addition, dissociation is a common phenomenon in BPD patients when experiencing stress, including unstable self-perception, disruptions in memory, consciousness, attention etc. ([@B40]). Previous studies have shown the prevalence rate of BPD to be between 0.7 and 5.9% in the general population ([@B16]; [@B38]), 15 and 25% in psychiatric inpatients and 10% in psychiatric outpatients ([@B29]). The variability in prevalence rates may be due to the use of different instruments and assessments.

At present, there are several instruments with proven psychometric properties to assess BPD-related symptoms and screen for BPD. Among these instruments, the Zanarini Rating Scale for Borderline Personality Disorder is a DSM-IV-based clinician-rated scale for assessing borderline symptom from a psychopathology perspective ([@B45]). The Borderline Personality Disorder Severity Index is a semi-structured interview instrument to evaluate the severity of borderline symptoms ([@B3]), and the Clinical Global Impression scale for BPD patients was designed to assess severity and post-intervention changes in patients with BPD ([@B34]). In addition to clinically administered instruments, there are several self-reported scales for assessing the symptoms and severity of BPD. For example, the Borderline Evaluation of Severity over Time measures the severity of BPD ([@B35]), and the Borderline Symptom List (BSL), can quickly evaluate typical symptoms of BPD ([@B12]). Compared with clinician-interviewed instruments, self-rated scales are more convenient and efficient, as they do not require clinical experts to carry out assessment.

The original version of the BSL (BSL-95) includes 95 items based on diagnosis according to the DSM-IV ([@B12]). Each item is scored on a 5-point Likert scale, ranging from 0 (none) to 4 (very strong). A Factor analysis revealed seven factors, including self-perception, emotion regulation, autoaggression, dysthymia, social isolation, intrusions and hostility ([@B12], [@B11]). While the BSL-95 is a reliable and valid instrument, it is time consuming due to an abundance of items ([@B11]; [@B22]). Therefore, a shortened version of the BSL (BSL-23) was developed by [@B10] to reduce participant burden. The BSL-23 has been reported to possess good psychometric properties in several languages ([@B22]; [@B37]; [@B33]). The BSL-23 and the BSL-95 are highly correlated, and the BSL-23 has been shown to be more sensitive to changes in symptoms after Dialectical Behavior Therapy than the BSL-95 ([@B10]). In addition, the BSL-23 effectively discriminates BPD from other psychiatric disorders, such as attention-deficit hyperactivity disorder and post-traumatic stress disorder ([@B10]; [@B33]). Due to differences in cultural backgrounds, it is necessary to examine the psychometric properties of the BSL-23 in the Chinese population, such that the credibility and effectiveness of the tool can be measured for research in China.

Prior findings have indicated that the BSL-23 is highly correlated with tests that measure depression and impulsiveness ([@B37]; [@B33]). In addition, childhood trauma and attachment style have previously been shown to be central characteristics of BPD ([@B25]; [@B26]), about 60--80% BPD patients reported traumatic experiences in childhood, which could contribute to insecure attachment ([@B7]). Therefore, the current study examined the correlations between the BSL-23 and other psychological scales that assess depression, impulsiveness, childhood trauma and attachment style. As the Chinese version of the Personality Diagnostic Questionnaire-4+ (PDQ-4+) has shown adequate psychometric properties to estimate personality disorders ([@B42]), the borderline subscale of PDQ-4+ was used to screen for BPD in the current study.

Materials and Methods {#s1}
=====================

Participants
------------

Participants were undergraduate students (*n* = 570) recruited from two large universities in Guangdong and Hunan province of China through convenience sampling and clinic outpatients (*n* = 323) from the psychological clinic of Second Xiangya Hospital. The clinical patients had diagnoses of depressive disorder, borderline personality disorder, anxiety disorder, schizophrenia, or other psychiatric disorders diagnosed by trained clinicians. The socio-demographic and clinical data of the two samples in detail were presented in **Table [1](#T1){ref-type="table"}**.

###### 

Socio-demographic characteristics of samples.

  Characteristic description   Undergraduate sample (*n* = 570)   Clinical sample (*n* = 323)    Chi-Square/t                   *p*      
  ---------------------------- ---------------------------------- ------------------------------ ------------------------------ -------- ---------
  Gender, n(%)                 Male vs. female                    153 vs. 417(26.84 vs. 73.16)   139 vs. 184(43.03 vs. 56.97)   24.56    \<0.001
  Age, Mean ± SD(range)        Years                              20.97 ± 1.01(17--26)           25.85 ± 9.49(16--64)           -9.21    \<0.001
  Diagnosis, n(%)              MDD                                /                              85(26.32)                      /        
                               BPD                                /                              83(25.70)                      /        
                               Anxiety disorder                   /                              54(16.72)                      /        
                               Schizophrenia                      /                              48(14.86)                      /        
                               Other                              /                              53(16.40)                      /        
  Scales, Mean ± SD(range)     BSL-23                             11.82 ± 11.86(0--62)           31.49 ± 22.72(0--92)           -14.48   \<0.001
                               PDQ-4+ -- borderline               2.08 ± 2.00(0--9)              4.09 ± 2.51(0--9)              -12.27   \<0.001
                               CESD                               36.62 ± 9.01(20--66)           49.82 ± 13.02(20--80)          -15.98   \<0.001
                               BIS-11                             64.70 ± 8.58(41--94)           70.44 ± 10.27(43--108)         -8.20    \<0.001
                               CTQ                                38.12 ± 9.27(28---80)          54.05 ± 11.66(32--108)         -20.55   \<0.001
                               ASQ -- Insecure                    105.09 ± 17.06(49--192)        114.58 ± 19.36(40--169)        -7.29    \<0.001

MDD, major depressive disorder; BPD, borderline personality disorder; other, other psychiatric disorder, such as somatoform disorder, obsessive--compulsive personality, stress related disorders; BSL-23, borderline Symptom List-23; PDQ-4+ -- borderline, personality diagnose questionnaire -- borderline subscale; CESD, center for epidemiologic studies depression scale; BIS-11, Barratt impulsiveness scale, 11th version; CTQ, childhood trauma questionnaire; ASQ, attachment style questionnaire.

Test-retest reliability was determined by a separate sample of 93 undergraduate students (24.70% male and 75.30% female; age range: 20--24; *M*~age~ = 21.52, *SD* = 0.69) who completed the BSL-23 twice (separated by 2 weeks).

All study procedures were approved by the Ethics Committee of Central South University of Second Xiangya Hospital. All participants signed an informed consent.

Instruments
-----------

### Borderline Symptom List (BSL-23)

The BSL-23 is a self-reported questionnaire that measures the severity of BPD symptomatology ([@B10]). Each item of the BSL-23 is scored on a 5-point Likert scale, ranging from 0 (none) to 4 (very strong). The total score is within the range of 0--92. Higher scores indicate more sever borderline symptoms. Previous studies revealed a single factor structure for the BSL-23 ([@B10]; [@B37]; [@B33]). The forward and back translation of the Chinese version of the BSL-23 was conducted by bilingual psychiatric experts, independently. No items were removed or changed during the translation. The final 23 items in Chinese proved comprehensible to Chinese participants in a preliminary study.

### Personality Diagnostic Questionnaire-4+ (PDQ-4+)-Borderline Subscale

The PDQ-4+ is a self-rated personality disorder questionnaire including 12 subscales corresponding to 12 types of personality disorders ([@B28]; [@B42]). The borderline subscale comprises 9 items each scored with 0 or 1. The total score, therefore ranges from 0 to 9. A total score ≥ 5 indicates a borderline personality disorder. The Chinese version of the PDQ-4+ has previously been shown to have acceptable psychometric properties ([@B42]). The current study adopted the borderline subscale of the PDQ-4+ to screen a BPD positive group (score of PDQ-4+ -Borderline subscale ≥ 5) and the BPD negative group (score of PDQ-4+ -Borderline subscale \< 5). In this study, the Cronbach's α of PDQ-4+ -Borderline subscale was 0.73 in undergraduate sample and 0.77 in clinical sample.

### Center for Epidemiologic Studies Depression Scale (CES-D)

The CES-D is a 20-item self-reported questionnaire evaluating depressive symptoms during the previous week ([@B17]). Each item is scored on a 4-point Likert scale, ranging from 1 (never) to 4 (very often). The total score of the CES-D, therefore ranges from 20 to 80. The psychometric properties of the CES-D were suitable in Chinese participants ([@B39]). The Cronbach's α of CES-D was 0.83 in undergraduate sample and 0.88 in clinical sample in this study.

### Barratt Impulsiveness Scale, 11th Version (BIS-11)

The BIS-11 measures impulsivity ([@B5]) and includes 30 items, each on a 4-point Likert scale, from 1 (never) to 4 (always). The total score ranges from 30 to 120. The BIS-11 contains three subscales (motor impulsivity, cognitive impulsivity, lack of planning). The Chinese version of the BIS-11 has shown good reliability and validity ([@B43]). In our samples, the Cronbach's α of BIS-11 was 0.69 in undergraduates and 0.68 in patients, respectively.

### Childhood Trauma Questionnaire (CTQ)

The CTQ includes 28 items that assess childhood abuse and neglect experiences ([@B8]). Each item is scored on a 5-point scale, ranging from 1 (never) to 5 (always). The total score ranges from 28 to 140. The CTQ contains five subscales: emotional abuse, physical abuse, sexual abuse, emotional neglect and physical neglect. The Chinese version of the CTQ has been shown to have adequate psychometric properties ([@B30]). In this study, the Cronbach's α of CTQ was 0.65 in undergraduate sample and 0.70 in clinical sample.

### Attachment Style Questionnaire (ASQ)

The ASQ is a 40-item self-reported questionnaire assessing attachment style ([@B18]). Each item is on a 6-point scale rating from 1 (totally disagree) to 6 (totally agree). The total score of the ASQ ranges from 40 to 240. The ASQ consists of five subscales: confidence, discomfort, relationships as secondary, need for approval, and preoccupation. The current study used the combined total of the last four subscales, which has previously been shown to reflect insecure attachment style ([@B24]). Scores range from 32 to 192 ([@B44]). The ASQ has been shown to have good reliability and validity in a Chinese population ([@B44]). In this study, the Cronbach's α of ASQ was 0.85 in undergraduate sample and 0.82 in clinical sample.

Data Analysis
-------------

Data were analyzed using IBM SPSS Statistics 20.0 and AMOS 17.0. Listwise deletion was used to handle the missing data in analysis. The results of skewness and kurtosis of each BSL-23 item indicated near normal distribution for most items, except items 5, 7, 11, 18, and 19.

First, a Confirmatory Factor Analysis (CFA) was performed to examine the one-factor structure of the BSL-23. The maximum likelihood (ML), a common method of estimation within CFA ([@B20]), was run. Several fit indexes were performed, including the parsimonious goodness of fit index (PGFI), the incremental fit index (IFI), the Tucker--Lewis index (TLI), the comparative fit index (CFI) and the root mean square error of approximation (RMSEA) with a 90% confidence interval (CI). Generally, PGFI ≥ 0.500, IFI ≥ 0.900, TLI ≥ 0.900, CFI ≥ 0.900, and RMSEA ≤ 0.080 is considered acceptable ([@B14]; [@B27]). To provide more information for the construct validity of the BSL-23, we also randomly split each sample in half and performed Exploratory Factor Analysis (EFA) and CFA in both samples, and the results of EFA and CFA with subsamples were shown in Supplementary Material.

Second, Cronbach's alpha, Omega, split-half reliability and the M~IC~ of the BSL-23 were calculated for both the undergraduate students and the clinical population. The test-retest stability was estimated in an undergraduate sub-sample (see above). The correlation coefficient was evaluated between the BSL-23 and the PDQ-4+-borderline subscale to assess criterion-related validity. The correlations between the BSL-23 and the CES-D, the BIS-11, the CTQ and the ASQ were also computed to assess convergent validity.

Third, to further assess criterion-related validity, the two samples were divided into two groups (BPD screening-positive group and BPD screening-negative group) according to the score on the PDQ-4+-borderline subscale (see above for cut-off). An independent samples *t*-test was performed to compare the difference in BSL-23 score between the two groups. Cohen's *d* was calculated to estimate the effect sizes ([@B15]).

Finally, the differences in BSL-23 scores between undergraduate students and clinical patients were examined by an independent samples *t*-test.

Results
=======

Confirmatory Factor Analysis
----------------------------

The fit indexes values obtained by the one-factor model were good both in the undergraduate student sample and in the clinical sample (**Table [2](#T2){ref-type="table"}**). The PGFI values were greater than 0.500, and the values of the IFI, the TLI and the CFI were all greater than 0.900 in both samples, indicating that the fitness of a one-factor model was acceptable. Moreover, values of the RMSEA were less than 0.080, suggesting a reasonable error approximation. The factor loading of all items of the BSL-23 in both samples ranged from 0.45 to 0.84 (**Table [3](#T3){ref-type="table"}**).

###### 

The fit indexes of the CFA in the undergraduate sample and clinical sample.

                                                                           RMSEA 90%CI   
  ------------------------ ------- ------- ------- ------- ------- ------- ------------- -------
  Undergraduate students   3.440   0.675   0.922   0.905   0.922   0.065   0.060         0.071
  Clinical patients        2.923   0.650   0.935   0.922   0.935   0.077   0.070         0.084

χ

2

, Chi-square; df, degrees of freedom; PGFI, parsimonious goodness-of-fit index; IFI, incremental fit index; TLI, Tucker-- Lewis index; CFI, comparative fit index; RMSEA, root-mean-square error of approximation; LO90 and HI90 indicate lower and upper end of the 90% confidence interval of the RMSEA.

###### 

The factor loading of each item of BSL-23 in the undergraduate sample and clinical sample.

          Undergraduate sample   Clinical sample           Undergraduate sample   Clinical sample
  ------- ---------------------- ----------------- ------- ---------------------- -----------------
  BSL01   0.45                   0.65              BSL13   0.67                   0.61
  BSL02   0.61                   0.78              BSL14   0.75                   0.77
  BSL03   0.47                   0.67              BSL15   0.57                   0.66
  BSL04   0.63                   0.74              BSL16   0.63                   0.71
  BSL05   0.59                   0.77              BSL17   0.64                   0.77
  BSL06   0.64                   0.64              BSL18   0.67                   0.75
  BSL07   0.54                   0.75              BSL19   0.58                   0.76
  BSL08   0.58                   0.77              BSL20   0.71                   0.72
  BSL09   0.57                   0.77              BSL21   0.77                   0.84
  BSL10   0.50                   0.67              BSL22   0.69                   0.83
  BSL11   0.71                   0.81              BSL23   0.70                   0.81
  BSL12   0.70                   0.78                                             

Reliability
-----------

In the undergraduate sample, the Cronbach's alpha was 0.93, the Omega coefficient was 0.95, the split-half coefficient was 0.89, and the M~IC~ was 0.38. The test-retest stability within 2 weeks was 0.62. For the clinical sample, the Cronbach's alpha was 0.97, and the Omega coefficient was 0.97, the split-half coefficient was 0.96 and the M~IC~ was 0.56.

Correlations Between BSL-23 and Other Psychological Scales
----------------------------------------------------------

There were significant correlations between the BSL-23 and the borderline subscale of the PDQ-4+, the CES-D, the BIS-11, the CTQ, and the insecure subscale of the ASQ in both the undergraduate (*r* = 0.35--0.60) and clinical (*r* = 0.35--0.70) samples (**Table [4](#T4){ref-type="table"}**).

###### 

Correlations between scores on BSL-23 and psychological scales in the undergraduate sample and clinical sample.

                                 BSL-23     
  ------------------------------ ---------- ----------
  PDQ-4+ - borderline subscale   0.50^∗∗^   0.70^∗∗^
  CESD                           0.60^∗∗^   0.69^∗∗^
  BIS-11 Total score             0.35^∗∗^   0.54^∗∗^
  CTQ Total score                0.43^∗∗^   0.35^∗∗^
  ASQ -- Insecure subscale       0.47^∗∗^   0.52^∗∗^

PDQ-4+ -- borderline subscale, personality diagnostic questionnaire -- borderline subscale; CESD, center for epidemiologic studies depression scale; BIS-11, Barratt impulsiveness scale, 11th version; CTQ, childhood trauma questionnaire; ASQ, attachment style questionnaire.

∗∗

p \< 0.01.

Differences Between the BPD Screening-Positive and Screening-Negative Groups on BSL-23 Scores
---------------------------------------------------------------------------------------------

Among the undergraduate sample, there were 85 participants (15%) in the BPD screening-positive group and 465 undergraduates in the BPD screening-negative group (85%). An independent samples *t*-test found a significantly higher BSL-23 score in the positive group compared to the negative group (*p* \< 0.01). Among the clinical sample, there were 146 patients (46%) in the BPD screening-positive group and 174 patients (64%) in the BPD screening-negative group. The patients in the positive group scored significantly higher than the patients in the negative group on the BSL-23 (*p* \< 0.01) (**Table [5](#T5){ref-type="table"}**).

###### 

BSL-23 total score in the BPD screening-positive and BPD screening-negative groups within both the undergraduate sample and clinical sample.

                           BPD positive (*n*)    BPD negative (*n*)    *p*       Cohen's *d*
  ------------------------ --------------------- --------------------- --------- -------------
  Undergraduate students   22.93 ± 15.15 (85)    9.72 ± 9.93 (465)     \<0.001   1.03
  Clinical patients        45.69 ± 20.80 (146)   19.48 ± 16.71 (174)   \<0.001   1.39

Differences Between Undergraduate Students and Clinical Patients on BSL-23 Scores
---------------------------------------------------------------------------------

Clinical patients scored significantly higher on the BSL-23 than the undergraduate students (*p* \< 0.01, Cohen's *d =* -1.09).

Discussion
==========

The BSL-23 has previously been shown to be a valid and efficient tool in the measurement of the severity of borderline symptoms ([@B37]; [@B33]). Compared to the initial version of the questionnaire, the BSL-23 not only has comparable psychometric properties, but also saves time and remarkably reduces the burden on participants. In agreement with prior studies ([@B10]; [@B37]; [@B33]), the current study, supported the one-factor structure model of the BSL-23 in both an undergraduate student sample and a clinical sample.

In the present study, the Cronbach's α of the BSL-23 was 0.93 in undergraduates, and 0.97 in clinical patients, both in agreement with prior studies reporting a range of 0.94 -- 0.97 ([@B10]; [@B37]; [@B33]). In addition, the Split-Half coefficients were high in both the undergraduate sample (0.89) and the clinical sample (0.96). The M~IC~ of the undergraduate sample was within the optimal range (0.10--0.50), as suggested by [@B13], while the M~IC~ of the clinical sample was a just over 0.50. Overall, the results of the current study support a high internal consistency of the Chinese version of the BSL-23.

Prior studies have shown a test-retest reliability within 1 week of *r* = 0.73 -- 0.84 ([@B10]; [@B37]; [@B33]), supporting the stability of BPD severity. However, the test-retest reliability within 2 weeks in the current study was less favorable (*r* = 0.62). The discrepancy is likely due to a longer test-retest time interval and the relatively smaller sample size in the current study.

There were significant correlations between the BSL-23 and the borderline subscale of the PDQ-4+ in both the undergraduate sample (*r* = 0.50) and the clinical sample (*r* = 0.70). While the BPD screening-positive group and BPD screening-negative group were determined by the PDQ-4+ BPD subscale, the two groups differed significantly in BSL-23 scores, further supporting reasonable criterion-related validity.

Previous studies have found that patients with BPD have a higher level of depression and anxiety than the general population ([@B32]; [@B21]; [@B23]). In the current study, we found that scores on the Chinese version of the BSL-23 correlated strongly with scores on the CES-D in both the undergraduate and the clinical samples, which was consistent with previous findings that scores on the BSL-23 correlate strongly with depression assessed by the Beck Depression Inventory ([@B11], [@B10]; [@B37]; [@B33]). Moreover, scores on the BSL-23 were highly correlated with the BIS-11 in both samples. These results indicate that BPD patients are characterized as more impulsive, as previous studies have shown that impulsivity measured by BIS was positively correlated with BSL-23 score ([@B37]; [@B33]). In summary, correlations between BPD symptoms measured by the BSL-23 and depression and impulsivity are consistent with the idea that BPD patients have a greater incidence of affective symptoms.

BSL-23 scores exhibited moderate to high correlations with CTQ scores in both the undergraduate sample and the clinical sample, suggesting that individuals with more serious borderline symptoms may have experienced more abuse and neglect in childhood. These findings are consistent with prior studies showing that 70% of BPD patients report childhood trauma experiences ([@B4]; [@B9]). Moreover, scores on the insecure attachment subscale showed a strong positive relationship with BSL-23 scores, suggesting that individuals with greater borderline symptoms also have a higher level of insecure attachment style, providing further support for Agrawal's conclusion that insecure attachment style strongly correlates with BPD regardless of measurement methods ([@B1]). A recent study found that insecure attachment partially mediates the relationship between childhood trauma and borderline symptoms ([@B6]). It may be that childhood trauma leads to insecure attachment, which consequently contributes to borderline symptoms. Further studies examining trauma, insecure attachment and borderline symptoms in one model are needed to clarify the relationship (e.g., mediating or moderator) among variables.

Lastly, BSL-23 scores were significantly greater among the clinical patients compared to the undergraduate students, indicating that the BSL-23 is an effective tool in the evaluation of BPD symptom severity. This finding provides support for the application of the BSL-23 in the Chinese population, both in the general population and in the clinical population.

In summary, this study confirmed the single factor structure and good psychometric properties of the BSL-23 in Chinese population, which provides an efficient and standardized instrument for Chinese clinicians to estimate the severity of BPD symptoms. With the BSL-23, clinicians can monitor the severity of BPD symptoms in the process of treatment, and assess the treatment efficacy in BPD patients, which will be helpful for further choice of intervention and therapy. While our findings supported the reliability and validity of the Chinese version of the BSL-23, some limitations should be considered. First, the homogeneity of the two samples in gender and age is not applicable, which limit the comparability of the two samples. Therefore, further studies are needed to reexamine the results we got in this study with two socio-demographic homogeneous samples (non-clinical and clinical sample). Second, the global measurement of dissociation of BPD was not included in this study. For dissociation is one of important symptoms in BPD, the relationship between dissociative symptoms and the BSL-23 should be examined in further research to provide comprehensive support for the BSL-23. Third, the clinical group consisted of a variety of psychological disorders, not just BPD diagnosis. Since BSL-23 is a tool for assessing the severity of BPD symptoms, examining its reliability and validity in patients with BPD will be more accurate and convincing, which might also contribute to clarify whether the Chinese version of the BSL-23 can distinguish BPD from other psychological disorders. Fourth, the patients in the current study did not receive psychotherapeutic intervention, and as such whether the Chinese version of the BSL-23 is sensitive to treatment changes cannot be discerned. Future studies are needed to compare BSL-23 scores between patients with BPD and patients with other psychological disorders, and to examine the sensitivity of BSL-23 to treatment effects in Chinese BPD patients.

Conclusion
==========

The BSL-23 is a self-rated scale that was developed to estimate the severity of BPD symptomatogy. In the current study, the one-factor structure of Chinese version of the BSL-23 was confirmed both in undergraduate students and in clinical patients. The Chinese version of the BSL-23 exhibited good internal consistency, criterion-related validity and high convergent validity. In addition, the BSL-23 was proven highly sensitive in the discrimination between BPD screening-positive individuals and BPD screening-negative individuals. Moreover, The BSL-23 was shown to have the capacity to discriminate BPD severity between a patient sample and undergraduate students. In all, the Chinese version of the BSL-23 shows satisfactory psychometric properties, offering an efficient and practical instrument for clinicians to assess borderline symptomatogy in Chinese population.
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